Ketamine for Treatment-Resistant Bipolar Disorder

Clinical trial NCT05004896 · COMPLETED

Trial details

NCT number: NCT05004896
Sponsor: Joshua Rosenblat
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bipolar Disorder Bipolar Depression Bipolar I Disorder Bipolar II Disorder

Start date: 2022-07-04
Primary completion: 2025-11-14
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.